Cargando…

Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma

BACKGROUND: In the present study, we aimed to investigate the role of epidermal growth factor receptor (EGFR) pathway in the up-regulation of programmed death ligand-1 (PD-L1) caused by radiotherapy (RT). MATERIALS AND METHODS: Tissue microarrays (TMA) consisting of glioma cancer specimens from 64 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xing, Shao, Yingjie, Jiang, Tianwei, Ding, Yun, Xu, Bin, Zheng, Xiao, Wang, Qi, Chen, Xin, Gu, Wendong, Wu, Changping, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835577/ https://www.ncbi.nlm.nih.gov/pubmed/29396299 http://dx.doi.org/10.1016/j.ebiom.2018.01.027

Ejemplares similares

Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: A meta-analysis
por: Wei, Wei, et al.
Publicado: (2018)

Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis
por: Zhang, Luo, et al.
Publicado: (2018)

Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database
por: Song, Xing, et al.
Publicado: (2017)

MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma
por: Shao, Yingjie, et al.
Publicado: (2019)

Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro
por: Guo, Qiuchen, et al.
Publicado: (2022)

Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis
por: Song, Xing, et al.
Publicado: (2016)

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes
por: Ding, Xing-Chen, et al.
Publicado: (2020)

Retrospective analysis of the bleeding risk induced by oral antiplatelet drugs during radiotherapy
por: Xi, Dan, et al.
Publicado: (2021)

Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
por: Zhang, Yan, et al.
Publicado: (2011)

Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma
por: Wang, Lei, et al.
Publicado: (2016)

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
por: Wu, Changping, et al.
Publicado: (2015)

Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer
por: Cui, Shaohua, et al.
Publicado: (2017)

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
por: Ali, Remah, et al.
Publicado: (2018)

Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma
por: Jiang, Guoxiang, et al.
Publicado: (2023)

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas
por: Zeng, Jing, et al.
Publicado: (2016)

Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamouscell carcinoma undergoing radical esophagectomy
por: Shao, Yingjie, et al.
Publicado: (2015)

Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment
por: Mudassar, Faiqa, et al.
Publicado: (2022)

Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
por: Baban, Babak, et al.
Publicado: (2015)

Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
por: Yang, Mengqi, et al.
Publicado: (2017)

Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway
por: Wu, Yuanyuan, et al.
Publicado: (2022)

ALKBH5/YTHDF2‐mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation
por: Shao, Yingjie, et al.
Publicado: (2023)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

CircNEIL3 promotes cervical cancer cell proliferation by adsorbing miR-137 and upregulating KLF12
por: Chen, Yuan, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis
por: Geng, Yiting, et al.
Publicado: (2016)

Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma
por: Du, Peng, et al.
Publicado: (2016)

Pim-1 inhibitor SMI-4a suppresses tumor growth in non-small cell lung cancer via PI3K/AKT/mTOR pathway
por: Jiang, Wenjie, et al.
Publicado: (2019)

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma
por: Mir Seyed Nazari, Pegah, et al.
Publicado: (2020)

Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
por: Zhang, Wencheng, et al.
Publicado: (2017)

Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis
por: Zhang, Luo, et al.
Publicado: (2018)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Function and clinical significance of circRNAs in solid tumors
por: Geng, Yiting, et al.
Publicado: (2018)

Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
por: Wang, Baoshan, et al.
Publicado: (2023)

Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
por: Jang, Yong Soo, et al.
Publicado: (2023)

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis
por: Zheng, Xiao, et al.
Publicado: (2017)

The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
por: Liu, Shujun, et al.
Publicado: (2020)

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
por: Hölzl, Dorothee, et al.
Publicado: (2021)

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023)

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)

Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients
por: Liu, Shujun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ppmq2m37vqoo3d9hpptfks75is